MAM
EW icon

Morse Asset Management’s Edwards Lifesciences EW Stock Holding History

Morse Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Sell
150
-14
-9% -$1.17K ﹤0.01% 309
2026
Q1 		$13.1K Hold
164
– – ﹤0.01% 283
2025
Q4 		$14K Buy
164
+39
+31% +$3.2K ﹤0.01% 269
2025
Q3 		$9.72K Buy
125
+25
+25% +$1.95K ﹤0.01% 268
2025
Q2 		$7.82K Buy
+100
New +$7.46K ﹤0.01% 277

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Morse Asset Management's EW Position: Q2 2026 in Review

Morse Asset Management reduced its Edwards Lifesciences (EW) stake by 8.5% in Q2 2026, selling an estimated $1.17K and leaving 150 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Morse Asset Management first reported a position in EW in Q2 2025 and has held it in 5 quarters since. The position peaked at $14K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Morse Asset Management held 150 shares of Edwards Lifesciences worth $13.6K as of Q2 2026.
  • Morse Asset Management sold 14 Edwards Lifesciences shares in Q2 2026, an estimated $1.17K.
  • Edwards Lifesciences made up ﹤0.01% of Morse Asset Management's portfolio in Q2 2026, its #309 holding.
  • Morse Asset Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • Morse Asset Management's Edwards Lifesciences position peaked at $14K in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.